Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule.
BACKGROUND: The 7-valent pneumococcal conjugate vaccine (PCV7) has demonstrated effectiveness against pneumococcal illnesses when administered as 3 infant doses plus a toddler dose (3+1 schedule) or as an abbreviated schedule of 2 infant doses plus a toddler dose (2+1 schedule). The 13-valent pneumo...
Main Authors: | Rodgers, G, Esposito, S, Principi, N, Gutierrez-Brito, M, Diez-Domingo, J, Pollard, A, Snape, MD, Martinón-Torres, F, Gruber, W, Patterson, S, Thompson, A, Gurtman, A, Paradiso, P, Scott, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
by: Beate Schmoele-Thoma, et al.
Published: (2019-03-01) -
The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.
by: Trück, J, et al.
Published: (2016) -
Differences in immunization site pain in toddlers vaccinated with either the 10- or the 13-valent pneumococcal conjugate vaccine
by: Trück, J, et al.
Published: (2018) -
13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01) -
Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
by: Hong-Yi Lee, et al.
Published: (2018-04-01)